Article

Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: In-vitro and ex-vivo drug-response studies

Malaria Molecular Epidemiology Unit, Institut Pasteur du Cambodge, Phnom Penh, Cambodia.
The Lancet Infectious Diseases (Impact Factor: 19.45). 09/2013; 13(12). DOI: 10.1016/S1473-3099(13)70252-4
Source: PubMed

ABSTRACT Artemisinin resistance in Plasmodium falciparum lengthens parasite clearance half-life during artemisinin monotherapy or artemisinin-based combination therapy. Absence of in-vitro and ex-vivo correlates of artemisinin resistance hinders study of this phenotype. We aimed to assess whether an in-vitro ring-stage survival assay (RSA) can identify culture-adapted P falciparum isolates from patients with slow-clearing or fast-clearing infections, to investigate the stage-dependent susceptibility of parasites to dihydroartemisinin in the in-vitro RSA, and to assess whether an ex-vivo RSA can identify artemisinin-resistant P falciparum infections.
We culture-adapted parasites from patients with long and short parasite clearance half-lives from a study done in Pursat, Cambodia, in 2010 (registered with ClinicalTrials.gov, number NCT00341003) and used novel in-vitro survival assays to explore the stage-dependent susceptibility of slow-clearing and fast-clearing parasites to dihydroartemisinin. In 2012, we implemented the RSA in prospective parasite clearance studies in Pursat, Preah Vihear, and Ratanakiri, Cambodia (NCT01736319), to measure the ex-vivo responses of parasites from patients with malaria. Continuous variables were compared with the Mann-Whitney U test. Correlations were analysed with the Spearman correlation test.
In-vitro survival rates of culture-adapted parasites from 13 slow-clearing and 13 fast-clearing infections differed significantly when assays were done on 0-3 h ring-stage parasites (10·88% vs 0·23%; p=0·007). Ex-vivo survival rates significantly correlated with in-vivo parasite clearance half-lives (n=30, r=0·74, 95% CI 0·50-0·87; p<0·0001).
The in-vitro RSA of 0-3 h ring-stage parasites provides a platform for the molecular characterisation of artemisinin resistance. The ex-vivo RSA can be easily implemented where surveillance for artemisinin resistance is needed.
Institut Pasteur du Cambodge and the Intramural Research Program, NIAID, NIH.

Download full-text

Full-text

Available from: Didier Menard, May 22, 2015
3 Followers
 · 
178 Views
    • "If >10 % of the patients are parasite positive at day 3, these samples need further confirmation and investigation (Ringwald, WHO Global Malaria Programme; WHO 2014). Apart from this, novel phenotypic assays have also been developed recently to detect artemisinin resistance (Witkowski et al. 2013). Genome study of Plasmodium falciparum is yet another method to catch artemisinin resistance (Winzeler and Manary 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Antimalarial drug resistance including artemisinin resistance in Plasmodium falciparum malaria is a major concern in combating malaria throughout the world. Delayed parasite clearance time (PCT) is indicative of emergence of artemisinin resistance. Herein, PCT has been monitored with the help of gold standard technique microscopy accompanied by a more sensitive real-time assay for academic purpose. After the administration of artemisinin based combination therapy, artesunate + sulfadoxine pyrimethamine (AS + SP), all the subjects were followed up to day 42 for monitoring the therapeutic efficacy of AS + SP in Bisra Community Health Centre (CHC), Sundergarh district in the state of Odisha in India. Further, representative samples were analyzed for L263E, E431K, A623E and S769N SNPs in Pfatpase6 gene and copy number polymorphisms in Pfmdr1 gene. Though all the samples were found parasite negative according to microscopy by the end of day 3 and attained adequate clinical and parasitological response (ACPR) at the end of day 42, real-time PCR showed day 3 positivity in 12 of the total analyzed samples (n = 43). This was further validated by end-point diagnostic PCR and correlated with high initial parasite load. E431K mutation was observed in 2 of the 12 samples (16.7 %) while the controls (n = 18) were all wild. L263E, A623E and S769N were wild in all the analyzed samples (n = 30). Pfmdr1 copy number analysis showed no change in the said trait. Conclusively, real-time PCR could support microscopy for better monitoring of PCT and may provide as an additional but useful research tool for artemisinin resistance studies.
    Parasitology Research 06/2015; DOI:10.1007/s00436-015-4577-x · 2.33 Impact Factor
  • Source
    • "Interestingly, for the P. falciparum laboratory strains examined, (3D7, D10 and 7G8), early rings (corresponding to a narrow window of 2–4 h post-invasion (p.i.) exhibited drug hypersensitivity, while later ring stages (up to $20 h p.i.) were quite resistant. More recent work has demonstrated the desired correlation between parasite clearance times and in vitro drug sensitivity utilising short (6 h) drug pulses and early ring stage parasites (0–3 h p.i.) (Witkowski et al., 2013a,b). This culminated in the identification of a genetic marker for drug resistance (Ariey et al., 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent reports demonstrate that failure of artemisinin-based antimalarial therapies is associated with an altered response of early blood stage Plasmodium falciparum. This has led to increased interest in the use of pulse assays that mimic clinical drug exposure for analysing artemisinin sensitivity of highly synchronised ring stage parasites. We report a methodology for the reliable execution of drug pulse assays and detail a synchronisation strategy that produces well-defined tightly synchronised ring stage cultures in a convenient time-frame.
    International Journal for Parasitology 08/2014; 44(12). DOI:10.1016/j.ijpara.2014.07.008 · 3.40 Impact Factor
  • Source
Show more